The inclusion of stroke in risk stratification for primary prevention of vascular events: The Northern manhattan study

Stroke

Volumn 42, Issue 10, 2011, Pages 2878-2882

  Dhamoon, Mandip S ^a   Moon, Yeseon Park ^b   Paik, Myunghee C ^b   Sacco, Ralph L ^c,d   Elkind, Mitchell S V ^e  

^a Department of Neurology   (United States)

^b Department of Medicine   (United States)

^c Evelyn F McKnight Brain Institute   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

epidemiology; risk factors; stroke management

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; RISK ASSESSMENT; SCORING SYSTEM; STROKE;

ADULT; AGED; AGED, 80 AND OVER; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRIMARY PREVENTION; PROSPECTIVE STUDIES; RISK; RISK FACTORS; STROKE;

EID: 80053338172     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.616912     Document Type: Article

References (18)

1. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847. (Pubitemid 28213628)
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
3. Dhamoon MS, Elkind MS. Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease. Circulation. 2010;121:2071-2078.
4. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:1583-1633. (Pubitemid 44313592)
5. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743-753. (Pubitemid 351640675)
6. Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke. 2004;35:2263-2269. (Pubitemid 39311247)
7. Echt DS, Liebson PR, Mitchell LB, Peter RW, Obias-Manno D, Barker AH, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781-788.
8. Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE, et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial. JAMA. 1994;271:999-1003.
9. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-172, discussion 207-212. (Pubitemid 351193639)
10. Framingham Heart Study Hard Coronary Artery Disease (10-year risk). Framingham Heart Study. Available at: www.framinghamheartstudy.org/risk/ hrdcoronary.html. Accessed November 1, 2009.
11. Heart Attack Risk Assessment, American Heart Association. Available at: www.heart.org/HEARTORG/Conditions/HeartAttack/HeartAttackToolsResources/ Heart-Attack-Risk-Assessment-UCM-303944-Article.jsp. Accessed August 22, 2010.
12. Framingham Heart Study General Cardiovascular Disease (10-year risk). Available at: www.framinghamheartstudy.org/risk/gencardio.html. Accessed November 12, 2010.
13. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388-391. (Pubitemid 34778969)
14. Dhamoon MS, Sciacca RR, Rundek T, Sacco RL, Elkind MS. Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Neurology. 2006;66:641-646. (Pubitemid 43739815)
15. Rosamond WD, Folsom AR, Chambless LE, Wang CH, McGovern PG, Howard G, et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1999;30:736-743. (Pubitemid 29156360)
16. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
17. Sacco RL, Khatri M, Rundek T, Xu Q, Gardener H, Boden-Albala B, et al. Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study). J Am Coll Cardiol. 2009;54:2303-2311.
18. Hurley LP, Dickinson LM, Estacio RO, Steiner JF, Havranek EP. Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors. Circ Cardiovasc Qual Outcomes. 2010;3:181-187.